Tempe, AZ and Irvine, CA. November 9th 2017: Applied Microarrays (“AMI”), the recognized leader in manufacturing services for next generation biosensors, and BioDot Inc., the market leader in precision dispensing equipment across the full range of research and diagnostic formats, today announce a strategic partnership to leverage joint capabilities to provide customer solutions.
“The biosensor market has evolved to require precision dispensing across volume ranges beyond our typical core competence in picoliter piezo printing. In addition, materials with challenging properties to dispense with piezo nozzles have been shown to provide advantages in particular biosensors. To maintain our position as the leader in manufacturing these devices it has become clear to us that BioDot is the partner of choice. Their equipment solutions can solve the technical challenges in the most cost-effective manner available on the market” AMI CEO Alastair Malcolm stated.
“Our dispensing solutions have propelled BioDot to the leadership position in manufacturing equipment across markets ranging from complex biosensors, microtiter plates and lateral flow devices. Under our new agreement, AMI is also sharing equipment technologies they have developed that have not previously been available in the general market, particularly in the low picoliter range. Together we will ensure BioDot offers unmatched customer-driven solutions in the precision dispensing market,” BioDot CEO Tom Tisone added.
About Applied Microarrays
AMI is a company headquartered in Tempe, AZ, which designs, optimizes and manufactures DNA and protein biosensors, and other microarrays on glass, plastic and semiconductors. AMI operates under ISO 9001 and ISO 13485 certification. Since acquiring GE Healthcare’s microarray business in 2007, AMI has evolved to become a full service provider for RUO and Dx devices.
About BioDot Inc.
Founded in 1994, BioDot manufactures precision quantitative fluid dispensing systems. Today with nearly 5000 units in the field BioDot is one of the largest suppliers of equipment in the diagnostic test market. Specializing in low volume dispensing, BioDot’s wide range of platforms serves customers from R&D through high volume manufacturing in the industrial, diagnostic, life science and medical product markets. A portfolio of proprietary dispensing technologies provides precision, non-contact dispensing from picoliter to microliter volumes. Today BioDot holds over 26 global patents in the area of low volume dispensing and novel applications that rely on its proprietary dispensing technology. BioDot is worldwide company with international offices in China and the United Kingdom. BioDot’s long-lasting relationships with customers is built on precision products and quality service around the world.